PLAY PODCASTS
eanCast: Weekly Neurology

eanCast: Weekly Neurology

ean.org

207 episodesEN

Show overview

eanCast: Weekly Neurology has been publishing since 2022, and across the 4 years since has built a catalogue of 207 episodes. That works out to roughly 85 hours of audio in total. Releases follow a weekly cadence.

Episodes typically run twenty to thirty-five minutes — most land between 20 min and 27 min — and the run-time is fairly consistent across the catalogue. None of the episodes are flagged explicit by the publisher. It is catalogued as a EN-language Science show.

The show is actively publishing — the most recent episode landed yesterday, with 26 episodes already out so far this year. Published by ean.org.

Episodes
207
Running
2022–2026 · 4y
Median length
23 min
Cadence
Weekly

From the publisher

Official neurology podcast of the European Academy of Neurology (EAN). Expert talks on general neurology, stroke, dementia, epilepsy & many more. New episodes every Monday. For neurology residents, clinicians & researchers. A resource for continuing medical education and lifelong learning.

Latest Episodes

View all 207 episodes

Ep. 207: Pills to face burnout and the role of occupational health therapists

Jun 28, 202632 min

Ep. 206: Genetics in ALS and frontotemporal dementia – from pathophysiology to treatment

Jun 21, 202619 min

Ep. 205: Neurofilaments as Biomarkers in ALS and frontotemporal dementia: From Bench to Bedside

Jun 14, 202634 min

Ep. 204: Social Cognition in ALS – beyond motor neurons

Jun 7, 202612 min

Ep. 203: Diagnostic challenges in ALS and frontotemporal dementia

May 31, 202627 min

Ep. 202: Clinical neurology Meets AI: Are we prepared?

May 24, 202626 min

Ep. 201: Inside the Black Box: Can Neurologists Trust AI?

May 17, 202621 min

Ep. 200: Human versus artificial intelligence: the contest

May 10, 202633 min

Ep. 199: AI Demystified: What It Is - and Isn’t

May 3, 202627 min

Ep. 198: The Complex Interaction between (Social) Media and Functional Neurological Disorders

Apr 26, 202629 min

Ep. 197: Functional Neurological Symptoms Co-existing with Movement Disorders: Clinical Challenges and Opportunities

Apr 19, 202638 min

Ep. 196: Is Biological Sex Important for the Development of Functional Neurological Disorders (FND)?

Apr 12, 202633 min

Ep. 195: Functional Neurological Disorder Across Europe: Bridging Gaps in Neurology Training and Clinical Practice

Apr 5, 202627 min

Ep. 194: Autism in children and adults: different or the same?

Moderator: Taras Voloshyn (Kyiv, Ukraine) Guests: Laavanya Damodaran (Birmingham, UK), Osman Malik (London, UK) In this episode, Taras Voloshyn speaks with Laavanya Damodaran and Osman Malik about autism spectrum disorder across the lifespan, with particular focus on the transition from childhood to adulthood. They discuss core diagnostic features, early clinical signs, evolving presentations in adult patients, and the challenges of recognition, comorbidities, and long-term multidisciplinary support in neurological and psychiatric practice.

Mar 29, 202648 min

Ep. 193: Understanding GBS and other inflammatory neuropathies across ages

Moderator: Francesco Germano (Genoa, Italy) Guest: Matteo Cataldi (Genoa, Italy) In this episode, Francesco Germano speaks with Matteo Cataldi about Guillain-Barré syndrome and other inflammatory neuropathies across the lifespan. They discuss key age-related differences in epidemiology, clinical presentation, diagnostic challenges, and management strategies in pediatric and adult patients, highlighting practical considerations for early recognition, risk assessment, and treatment in neurological practice.

Mar 22, 202628 min

Ep. 192: Movement disorders in children and adults: different or the same?

Moderator: Natalia Szejko (Warsaw, Poland) Guests: Tammy Hedderly (London, UK), Alexander Münchau (Lübeck, Germany) In this episode, Natalia Szejko speaks with Tammy Hedderly and Alexander Münchau about the similarities and differences in movement disorders across the lifespan. They discuss the clinical evolution of tics and stereotypies from childhood to adulthood, the distinct diagnostic implications of dystonia and parkinsonism in pediatric versus adult populations, and the importance of multidisciplinary care and acceptance-based strategies in neurological practice.

Mar 15, 202636 min

Ep. 191: FND in children and adults: different or the same?

Moderator: Meagan Watson (Denver, USA) Guests: Pavlina Danhofer (Brno, Czech Republic), Natalia Szejko (Warsaw, Poland) In this episode, Meagan Watson speaks with Pavlína Danhofer and Natalia Szejko about whether functional neurological disorders (FNDs) present differently in children and adults. They discuss age-specific clinical features, comorbidities, developmental and family context, diagnostic challenges, and the role of early, tailored multidisciplinary management to improve outcomes in neurological practice.

Mar 8, 202639 min

Ep. 190: Parkinson’s disease – more than a movement disorder

In this episode, Yıldız Değirmenci speaks with Julie Hall and Marit Ruitenberg about non-motor symptoms in Parkinson’s disease, focusing on anxiety and cognitive impairment. They examine their clinical profiles, early detection challenges including neuropsychological markers, interactions with motor manifestations, and implications for comprehensive assessment and individualized management in neurological practice.

Mar 1, 202620 min

Ep. 189: Red flags of treatable (spino)cerebellar ataxias

Moderator: João Durães (Coimbra, Portugal) Guests: Paola Giunti (London, UK), Lidia Sarro (Milan, Italy) In this episode, João Durães, Paola Giunti and Lidia Sarro provide a rigorous examination of the diagnostic and therapeutic landscape of treatable ataxias, focusing on rare variants. The discussion first delineates autoimmune etiologies, such as anti-GAD, paraneoplastic, and gluten-related syndromes, before transitioning to a detailed review of acquired and genetic metabolic disorders, including vitamin deficiencies, NPC, Refsum disease, Glut1 deficiency, CTX, and Wilson’s disease among others. By highlighting critical clinical and paraclinical "red flags," the contributors offer a framework for accelerating differential diagnosis. The session concludes with an analysis of contemporary pharmacological advancements, notably the recent EMA approval for Friedreich’s Ataxia and the efficacy of repurposed drugs in treating genetic forms such as EA1/2 and SCA27B.

Feb 22, 202645 min

Ep. 188: Red flags of treatable rare myopathies

Moderator: Olimpia Musumeci (Messina, Italy) Guests: Antonio Toscano (Messina, Italy), Marianne De Visser (Amsterdam, Netherlands) In this episode, Olimpia Musumeci speaks with Antonio Toscano and Marianne de Visser about hereditary, particularly metabolic, and acquired myopathies, especially idiopathic inflammatory myopathies amenable to treatment. They review advances in pathophysiology, diagnostic approaches and novel therapies, highlighting clinical red flags and strategies that have a significant impact on timely diagnosis and management in daily neurological practice.

Feb 15, 202632 min
2022 ean.org